Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
5/21/2007
 
First Published:
8/1/1998
1.
Phase III Randomized Study of Porfiromycin as Adjuvant Therapy to Radiotherapy in Patients With Stage III or IV Head and Neck Cancer (Summary Last Modified 01/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
Pharmaceutical / Industry
BOEH-PORF-96-001
BOEH-BI-1164.1, COVANCE-1403, VION-PORF-96-001, NCI-V98-1416, NCT00003328
Last Modified:
6/1/2000
2.
Phase III Randomized Study of Mitomycin vs Porfiromycin as an Adjunct to Radiotherapy for Epidermoid Carcinomas of the Head and Neck (Summary Last Modified 06/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
20 to 80
Other
YALE-HIC-6611
NCI-V92-0190, NCT00002507
Last Modified:
2/1/1991
3.
Phase I Study of Porfiromycin and Radiotherapy in Patients with Head and Neck Cancer (Summary Last Modified 02/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
20 to 80
NCI
YALE-HIC-4911
NCI-T88-0217D, T88-0217
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute